Obstructive sleep apnea: Therapies other than CPAP

Journal of Association of Physicians of India

Volumn 52, Issue FEB, 2004, Pages 143-151

  Chhajed, P N ^a   Chhajed, Trupti P ^a   Tamm, M ^a   Strobel, W ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BEHAVIOR THERAPY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DRUG COMBINATION; FEMALE; HOSPITALIZATION; HUMAN; INDIA; LASER SURGERY; MALE; METHODOLOGY; MULTIMODALITY CANCER THERAPY; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK ASSESSMENT; SLEEP APNEA SYNDROME; TREATMENT OUTCOME; WEIGHT REDUCTION;

BEHAVIOR THERAPY; COMBINED MODALITY THERAPY; CONTINUOUS POSITIVE AIRWAY PRESSURE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INDIA; LASER SURGERY; MALE; POLYSOMNOGRAPHY; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SLEEP APNEA, OBSTRUCTIVE; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 13744249548     PISSN: 00045772     EISSN: 00045772     Source Type: Journal    
DOI: None     Document Type: Review

References (103)

1. Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993;328:1230-35.
2. Nieto FJ, Young TB, Lind BK, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 2000;283:1829-36.
3. Peppard PE, Young T, Palta M, et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000;342:1378-84.
4. Parish JM, Shepard JW, Jr. Cardiovascular effects of sleep disorders. Chest 1990;97:1220-26.
5. Schafer H, Koehler U, Ewig S, et al. Obstructive sleep apnea as a risk marker in coronary artery disease. Cardiology 1999;92:79-84.
6. Bradley TD, Rutherford R, Grossman RF, et al. Role of daytime hypoxemia in the pathogenesis of right heart failure in the obstructive sleep apnea syndrome. Am Rev Respir Dis 1985;131:835-9.
7. Partinen M, Palomaki H. Snoring and cerebral infarction. Lancet 1985;2:1325-26.
8. Hermann DM, Bassetti CL Sleep-disordered breathing and stroke. Curr Opin Neurol 2003;16:87-90.
9. Sullivan CE, Issa FG, Berthon-Jones M, et al. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet 1981;1:862-865.
10. Guilleminault C, Stoohs R, Clerk A. Daytime somnolence: therapeutic approaches. Neurophysiol Clin 1993;23:23-33.
11. Pepin JL, Leger P, Veale D. et al. Side effects of nasal continuous positive airway pressure in sleep apnea syndrome. Study of 193 patients in two French sleep centers. Chest 1995;107:375-81.
12. Fleury B, Rakotonanahary D, Hausser-Hauw C, et al. Objective patient compliance in long-term use of nCPAP. Eur Respir J 1996;9:2356-59.
13. Engleman HM, Martin SE, Deary IJ, et al. Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome. Lancet 1994;343:572-5.
14. Kribbs NB, Pack AI, Kline LR, et at. Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis 1993;147:887-95.
15. Grunstein R, Wilcox I, Yang TS, et al. Snoring and sleep apnoea in men: association with central obesity and hypertension. Int J Obes Relat Metab Disord 1993;17:533-40.
16. Strobel RJ, Rosen RC. Obesity and weight loss in obstructive sleep apnea: a critical review. Sleep 1996;19:104-15.
17. Horner RL, Mohiaddin RH, Lowell DG, et al. Sites and sizes of fat deposits around the pharynx in obese patients with obstructive sleep apnoea and weight matched controls. Eur Respir J 1989;2:613-22.
18. Brown IB, McClean PA, Boucher R, et al. Changes in pharyngeal cross-sectional area with posture and application of continuous positive airway pressure in patients with obstructive sleep apnea. Am Rev Respir Dis 1987;136:628-32.
19. Suratt PM, McTier RF, Wilhoit SC. Collapsibility of the nasopharyngeal airway in obstructive sleep apnea. Am Rev Respir Dis 1985;132:967-71.
20. Peppard PE, Young T, Palta M, et al. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA 2000;284:3015-21.
21. Magalang UJ, Mador MJ. Behavioral and pharmacologie therapy of obstructive sleep apnea. Clin Chest Med 2003;24:343-53.
22. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999;22:667-89.
23. Sampol G, Munoz X, Sagales MT, et al. Long-term efficacy of dietary weight loss in sleep apnoea/hypopnoea syndrome. Eur Respir J 1998;12:1156-59.
24. Oksenberg A, Silverberg DS, Arons E, et al. Positional vs nonpositional obstructive sleep apnea patients: anthropomorphic, nocturnal polysomnographic, and multiple sleep latency test data. Chest 1997;112:629-39.
25. Cartwright RD. Effect of sleep position on sleep apnea severity. Sleep 1984;7:110-14.
26. Jan MA, Marshall I, Douglas NJ. Effect of posture on upper airway dimensions in normal human. Am J Respir Crit Care Med 1994;149:145-8.
27. Martin SE, Marshall I, Douglas NJ. The effect of posture on airway caliber with the sleep-apnea/hypopnea syndrome. Am J Respir Crit Care Med 1995;152:721-4.
28. Neill AM, Angus SM, Sajkov D, et al. Effects of sleep posture on upper airway stability in patients with obstructive sleep apnea. Am J Respir Crit Care Med 1997;155:199-204.
29. Penzel T, Moller M, Becker HF, et al. Effect of sleep position and sleep stage on the Collapsibility of the upper airways in patients with sleep apnea. Sleep 2001;24:90-95.
30. Jokic R, Klimaszewski A, Crossley M, et al. Positional treatment vs continuous positive airway pressure in patients with positional obstructive sleep apnea syndrome. Chest 1999;115:771-81.
31. Brownell LG, West P, Sweatman P, et al. Protriptyline in obstructive sleep apnea: a double-blind trial. N Engl J Med 1982;307:1037-42.
32. Rubin AH, Alroy GG, Peled-R, et al. Preliminary clinical experience with imipramine HQ in the treatment of sleep apnea syndrome. Eur Neurol 1986;25:81-5.
33. Whyte KF, Gould GA, Airlie MA, et al. Role of protriptyline and acetazolamide in the sleep apnea/hypopnea syndrome. Sleep 1988;11:463-72.
34. Berger AJ, Bayliss DA, Viana F. Modulation of neonatal rat hypoglossal motor neuron excitability by serotonin. Neurosci Lett 1992;143:164-8.
35. Kubin L, Tojima H, Davies RO, et al. Serotonergic excitatory drive to hypoglossal motoneurons in the decerebrate cat. Neurosci Lett 1992;139:243-8.
36. Veasey SC, Panckeri KA, Hoffman EA, et al. The effects of serotonin antagonists in an animal model of sleep-disordered breathing. Am J Respir Crit Care Med 1996;153:776-86.
37. Veasey SC, Fenik P, Panckeri K, et al. The effects of trazodone with L-tryptophan on sleep-disordered breathing in the English bulldog. Am J Respir Crit Care Med 1999;160:1659-67.
38. Schmidt HS. L-tryptophan in the treatment of impaired respiration in sleep, Bull Eur Physiopathol Respir 1983;19:625-29.
39. Hanzel DA, Proia NG, Hudgel DW. Response of obstructive sleep apnea to fluoxetine and protriptyline. Chest 1991;100:416-21.
40. Popovic RM, White DP. Upper airway muscle activity in normal women: influence of hormonal status. J Appl Physiol 1998;84:1055-62.
41. Cistulli PA, Barnes DJ, Grunstein RR, et al. Effect of short-term hormone replacement in the treatment of obstructive sleep apnoea in postmenopausal women. Thorax 1994;49:699-702.
42. Stewart DA, Grunstein RR, Berthon-Jones M, et al. Androgen blockade does not affect sleep-disordered breathing or chemosensitivity in men with obstructive sleep apnea. Am Rev Respir Dis 1992;146:1389-93.
43. Rajagopal KR, Abbrecht PH, Jabbari B. Effects of medroxyprogesterone acetate in obstructive sleep apnea. Chest 1986;90:815-21.
44. Cook WR, Benich JJ, Wooten SA. Indices of seventy of obstructive sleep apnea syndrome do not change during medroxyprogesterone acetate therapy. Chest 1989;96:262-66.
45. Sutton FD, Jr., Zwillich CW, Creagh CE, et ol. Progesterone for outpatient treatment of Pickwickian syndrome. Ann Intern Med 1975;83:476-79.
46. Bayliss DA, Millhorn DE, Gallman EA, et al. Progesterone stimulates respiration through a central nervous system steroid receptor-mediated mechanism in cat. Proc Natl Acad Sci USA 1987;84:7788-92.
47. Hannhart B, Pickett CK, Moore LG. Effects of estrogen and progesterone on carotid body neural output responsiveness to hypoxia. J Appl Physiol 1990;68:1909-16.
48. Strohl KP, Hensley MJ, Saunders NA, et at. Progesterone administration and progressive sleep apneas. JAMA 1981;245:1230-32.
49. Orr WC, Imes NK, Martin RJ. Progesterone therapy in obese patients with sleep apnea. Arch Intern Med 1979;139:109-11.
50. Massumi RA, Winnacker JL. Severe depression of the respiratory center in myxedema. Am J Med 1964;36:876-82.
51. Rajagopal KR, Abbrecht PH, Derderian SS, et al. Obstructive sleep apnea in hypothyroidism. Ann intern Med 1984;101:491-94.
52. Lin CC, Tsan KW, Chen PJ. The relationship between sleep apnea syndrome and hypothyroidism. Chest 1992;102:1663-67.
53. Grunstein RR, Sullivan CE. Sleep apnea and hypothyroidism: mechanisms and management. Am J Med 1988;85:775-79.
54. Orr WC, Males JL, Imes NK. Myxedema and obstructive sleep apnea. Am J Med 1981;70:1061-66.
55. Skatrud J, Iber C, Ewart R, et al. Disordered breathing during sleep in hypothyroidism. Am Rev Respir Dis 1981;124:325-29.
56. Tojima H, Kunitomo F, Kimura H, et al. Effects of acetazolamide in patients with the sleep apnoea syndrome. Thorax 1988;43:113-119.
57. Sharp JT, Druz WS, D'Souza V, et al. Effect of metabolic acidosis upon sleep apnea. Chest 1985;87:619-24.
58. DeBacker WA, Verbraecken J, Willemen M, et al. Central apnea index decreases after prolonged treatment with acetazolamide. Am J Respir Crit Care Med 1995;151:87-91.
59. Hackett PH, Roach RC, Harrison GL, et al. Respiratory stimulants and sleep periodic breathing at high altitude. Almitrine versus acetazolamide. Am Rev Respir Dis 1987;135:896-98.
60. Findley LJ, Boykin M, Fallon T, et al. Plasma adenosine and hypoxemia in patients with sleep apnea. J Appl Physiol 1988;64:556-61.
61. Hudgel DW, Thanakitcharu S. Pharmacologic treatment of sleep-disordered breathing. Am J Respir Crit Care Med 1998;158:691-99.
62. Espinoza H, Antic R, Thornton AT, et al The effects of aminophylline on sleep and sleep-disordered breathing in patients with obstructive sleep apnea syndrome. Am Rev Respir Dis 1987;136:80-84.
63. Javaheri S, Parker TJ, Wexler L, et al. Effect of theophylline on sleep-disordered breathing in heart failure. N Engl J Med 1996;335:562-67.
64. Weichler U, Herres-Mayer B, Mayer J, et al. Influence of antihypertensive drug therapy on sleep pattern and sleep apnea activity. Cardiology 1991;78:124-30.
65. Kantola I, Rauhala E, Erkinjuntti M, et al. Sleep disturbances in hypertension: a double-blind study between isradipine and metoprolol. J Cardiovasc Pharmacol 1991;18:S41-45.
66. Garrigue S, Bordier P, Jais P, et al. Benefit of atrial pacing in sleep apnea syndrome. N Engl J Med 2002;346:404-12.
67. Gislason T, Almqvist M, Boman G, et al. Increased CSF opioid activity in sleep apnea syndrome. Regression after successful treatment. Chest 1989;96:250-54.
68. Gothe B, Strohl KP, Levin S, et al. Nicotine: a different approach to treatment of obstructive sleep apnea. Chest 1985;87:11-17.
69. Davila DG, Hurt RD, Offord KP, et al. Acute effects of transdermal nicotine on sleep architecture, snoring, and sleep-disordered breathing in nonsmokers. Am J Respir Crit Care Med 1994;150:469-74.
70. Pack AI, Black JE, Schwartz JR, et al. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea. Am J Respir Crit Care Med 2001;164:1675-81.
71. Kingshott RN, Vennelle M, Coleman EL, et al. Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of residual excessive daytime sleepiness in the sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 2001;163:918-23.
72. Ono T, Lowe AA, Ferguson KA, et al. The effect of the tongue retaining device on awake genioglossus muscle activity in patients with obstructive sleep apnea. Am J Orthod Dentofacial Orthop 1996;110:28-35.
73. Ono T, Lowe AA, Ferguson KA, et al. A tongue retaining device and sleep-state genioglossus muscle activity in patients with obstructive sleep apnea. Angle Orthod 1996;66:273-80.
74. Yoshida K. Effect of a prosthetic appliance for treatment of sleep apnea syndrome on masticatory and tongue muscle activity. J Prosthet Dent 1998;79:537-544.
75. Mehta A, Qian J, Petocz P, et al. A randomized, controlled study of a mandibular advancement splint for obstructive sleep apnea. Am J Respir Crit Care Med 2001;163:1457-61.
76. Cartwright RD. Predicting response to the tongue retaining device for sleep apnea syndrome. Arch Otolaryngol 1985;111:385-88.
77. Clark GT, Blumenfeld I, Yoffe N, et al. A crossover study comparing the efficacy of continuous positive airway pressure with anterior mandibular positioning devices on patients with obstructive sleep apnea. Chest 1996;109:1477-83.
78. Ferguson KA, Ono T, Lowe AA, et al. A randomized crossover study of an oral appliance vs nasal-continuous positive airway pressure in the treatment of mild-moderate obstructive sleep apnea. Chest 1996;109:1269-75.
79. Ferguson KA, Ono T, Lowe AA, et al. A short-term controlled trial of an adjustable oral appliance for the treatment of mild to moderate obstructive sleep apnoea. Thorax 1997;52:362-68.
80. Randerath WJ, Heise M, Hinz R, et al. An individually adjustable oral appliance vs continuous positive airway pressure in mild-to-moderate obstructive sleep apnea syndrome. Chest 2002;122:569-75.
81. Engleman HM, McDonald JP, Graham D, et al. Randomized crossover trial of two treatments for sleep apnea/hypopnea syndrome: continuous positive airway pressure and mandibular repositioning splint. Am J Respir Crit Care Med 2002;166:855-59.
82. Gotsopoulos H, Chen C, Qian J, et al. Oral appliance therapy improves symptoms in obstructive sleep apnea: a randomized, controlled trial. Am J Respir Crit Care Med 2002;166:743-48.
83. Ng AT, Gotsopoulos H, Qian J, et al. Effect of oral appliance therapy on upper airway collapsibility in obstructive sleep apnea. Am J Respir Crit Care Med 2003;168:238-41.
84. Petit FX, Pepin JL, Bettega G, et al. Mandibular advancement devices: rate of contraindications in 100 consecutive obstructive sleep apnea patients. Am J Respir Crit Care Med 2002;166:274-78.
85. Kuhlo W, Doll E, Franck MC. [Successful management of Pickwickian syndrome using long-term tracheostomy]. Dtsch Med Wochenschr 1969;94:1286-90.
86. Fujita S, Conway W, Zorick F, et al. Surgical correction of anatomic azbnormalities in obstructive sleep apnea syndrome: uvulopalatopharyngoplasty. Otolaryngo Head Neck Surg 1981;89:923-34.
87. Sher AE. Upper airway surgery for obstructive sleep apnea. In: McNicholas WT, Phillipson EA, eds. Breathing Disorders in Sleep. London: Harcourt Publishers Ltd, 2002; 134.
88. McNamara F, Sullivan CE. Treatment of obstructive sleep apnea syndrome in children. Sleep 2000;23:S142-46.
89. Jain A, Sahni JK. Polysomnographic studies in children undergoing adenoidectomy and/or tonsillectomy. J Laryngol Otol 2002;116:711-15.
90. Shintani T, Asakura K, Kataura A. The effect of adenotonsillectomy in children with OSA. Int J Pediatr Otorhinolaryngol 1998;44:51-58.
91. Verse T, Kroker BA, Pirsig W, et al. Tonsillectomy as a treatment of obstructive sleep apnea in adults with tonsillar hypertrophy. Laryngoscope 2000;110:1556-59.
92. Sher AE, Schechtman KB, Piccirillo JF. The efficacy of surgical modifications of the upper airway in adults with obstructive sleep apnea syndrome. Sleep 1996;19:156-77.
93. 2 laser: laser-assisted UPPP. J Otolaryngol 1994;23:391-4.
94. Krespi YP, Pearlman SJ, Keidar A. Laser-assisted uvulapalatoplasty for snoring. J Otolaryngol 1994;23:328-34.
95. Walker RP, Grigg-Damberger MM, Gopalsami C, et al. Laser-assisted uvulopalatoplasty for snoring and obstructive sleep apnea: results in 170 patients. Laryngoscope 1995;105:938-43.
96. Mickelson SA, Rosenthal L. Midline glossectomy and epiglottidectomy for obstructive sleep apnea syndrome. Laryngoscope 1997;107:614-619.
97. Walker RP, Grigg-Damberger MM, Gopalsami C. Laser-assisted uvulopalatoplasty for the treatment of mild, moderate, and severe obstructive sleep apnea. Laryngoscope 1999;109:79-85.
98. Walker RP, Grigg-Damberger MM, Gopalsami C. Uvulopalatopharyngoplasty versus laser-assisted uvulopalatoplasty for the treatment of obstructive sleep apnea. Laryngoscope 1997;107:76-82.
99. Finkelstein Y, Shapiro-Feinberg M, Stein G, et al. Uvulopalatopharyngoplasty vs laser-assisted uvulopalatoplasty. Anatomical considerations. Arch Otolaryngol Head Neck Surg 1997;123:265-76.
100. Kuo PC, West RA, Bloomquist DS, et al. The effect of mandibular osteotomy in three patients with hypersomnia sleep apnea. Oral Surg Oral Med Oral Pathol 1979;48:385-92.
101. Bear SE, Priest JH. Sleep apnea syndrome: correction with surgical advancement of the mandible. J Oral Surg 1980;38:543-49.
102. Li KK. Surgical management of obstructive sleep apnea. Clin Chest Med 2003;24:365-70.
103. Hochban W, Conradt R, Brandenburg U, et al. Surgical maxillofacial treatment of obstructive sleep apnea. Plast Reconstr Surg 1997;99:619-26; discussion 627-28.